Publications

  • Manuscript Engineering cancer antigen-specific T cells to overcome the immunosuppressive effects of TGF-β.

    The Journal of Immunology 2022 Jan 1;208(1):169-180.
    Jonathan DS, et al.
    PDF upon request.